These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 23053264)

  • 1. Formation of active products of benzaldehyde dimethane sulfonate (NSC 281612, DMS612) in human blood and plasma and their activity against renal cell carcinoma lines.
    Parise RA; Anyang BN; Eiseman JL; Egorin MJ; Covey JM; Beumer JH
    Cancer Chemother Pharmacol; 2013 Jan; 71(1):73-83. PubMed ID: 23053264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of the metabolism of benzaldehyde dimethane sulfonate (NSC 281612, DMS612).
    Parise RA; Eiseman JL; Clausen DM; Kicielinski KP; Hershberger PA; Egorin MJ; Beumer JH
    Cancer Chemother Pharmacol; 2015 Sep; 76(3):537-46. PubMed ID: 26193988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of the aldehyde dehydrogenase inhibitor disulfiram on the plasma pharmacokinetics, metabolism, and toxicity of benzaldehyde dimethane sulfonate (NSC281612, DMS612, BEN) in mice.
    Parise RA; Beumer JH; Clausen DM; Rigatti LH; Ziegler JA; Gasparetto M; Smith CA; Eiseman JL
    Cancer Chemother Pharmacol; 2013 Dec; 72(6):1195-204. PubMed ID: 24061865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro evaluation of dimethane sulfonate analogues with potential alkylating activity and selective renal cell carcinoma cytotoxicity.
    Mertins SD; Myers TG; Holbeck SL; Medina-Perez W; Wang E; Kohlhagen G; Pommier Y; Bates SE
    Mol Cancer Ther; 2004 Jul; 3(7):849-60. PubMed ID: 15252146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A phase i study of DMS612, a novel bifunctional alkylating agent.
    Appleman LJ; Balasubramaniam S; Parise RA; Bryla C; Redon CE; Nakamura AJ; Bonner WM; Wright JJ; Piekarz R; Kohler DR; Jiang Y; Belani CP; Eiseman J; Chu E; Beumer JH; Bates SE
    Clin Cancer Res; 2015 Feb; 21(4):721-9. PubMed ID: 25467180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous analysis of oral anticancer drugs for renal cell carcinoma in human plasma using liquid chromatography/electrospray ionization tandem mass spectrometry.
    Takasaki S; Tanaka M; Kikuchi M; Maekawa M; Kawasaki Y; Ito A; Arai Y; Yamaguchi H; Mano N
    Biomed Chromatogr; 2018 Jun; 32(6):e4184. PubMed ID: 29283445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BMP-2 inhibits tumor-initiating ability in human renal cancer stem cells and induces bone formation.
    Wang L; Park P; La Marca F; Than KD; Lin CY
    J Cancer Res Clin Oncol; 2015 Jun; 141(6):1013-24. PubMed ID: 25431339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simultaneous determination of sunitinib and its two metabolites in plasma of Chinese patients with metastatic renal cell carcinoma by liquid chromatography-tandem mass spectrometry.
    Qiu F; Bian W; Li J; Ge Z
    Biomed Chromatogr; 2013 May; 27(5):615-21. PubMed ID: 23108983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and validation of LC-MS/MS assays for the quantification of bendamustine and its metabolites in human plasma and urine.
    Dubbelman AC; Tibben M; Rosing H; Gebretensae A; Nan L; Gorman SH; Robertson P; Schellens JH; Beijnen JH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Apr; 893-894():92-100. PubMed ID: 22426286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of a novel liquid chromatography/tandem mass spectrometry method for the determination of antazoline in human plasma: Result of ELEPHANT-I [ELEctrophysiological, pharmacokinetic and hemodynamic effects of PHenazolinum (ANTazoline mesylate)] human pharmacokinetic study.
    Giebułtowicz J; Piotrowski R; Baran J; Kułakowski P; Wroczyński P
    J Pharm Biomed Anal; 2016 May; 123():113-9. PubMed ID: 26895496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The alkylator treosulfan shows activity towards human renal-cell carcinoma in vivo and in vitro.
    Köpf-Maier P
    In Vivo; 1998; 12(3):275-88. PubMed ID: 9706471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liquid chromatography-tandem mass spectrometry assay for the quantitation of plagiochin E and its main metabolite plagiochin E glucuronides in rat plasma.
    Xing J; Lv B; Xie C; Qu J; Lou H
    J Pharm Biomed Anal; 2008 Aug; 47(4-5):949-53. PubMed ID: 18420369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of resveratrol and its sulfate and glucuronide metabolites in plasma by LC-MS/MS and their pharmacokinetics in dogs.
    Muzzio M; Huang Z; Hu SC; Johnson WD; McCormick DL; Kapetanovic IM
    J Pharm Biomed Anal; 2012 Feb; 59():201-8. PubMed ID: 22079044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of O6-methylguanine-DNA methyltransferase expression on the drug resistance of clear cell renal cell carcinoma.
    Ge N; Guo L; Zhang J; Lin Z; Li Y; Liu Y; Kong F; Fang X; Zhao S
    Jpn J Clin Oncol; 2015 Sep; 45(9):860-6. PubMed ID: 26185135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mouse pharmacokinetics and metabolism of the phenylurea thiocarbamate NSC 161128.
    Koubek EJ; Kudgus RA; Walden CA; McGovern RM; Covey JM; Ames MM; Reid JM
    Cancer Chemother Pharmacol; 2022 Aug; 90(2):161-174. PubMed ID: 35896839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting metabolomics analysis of the sunscreen agent 2-ethylhexyl 4-(N,N-dimethylamino)benzoate in human urine by automated on-line solid-phase extraction-liquid chromatography-tandem mass spectrometry with liquid chromatography-time-of-flight/mass spectrometry confirmation.
    León-González Z; Ferreiro-Vera C; Priego-Capote F; de Castro MD
    J Chromatogr A; 2011 May; 1218(20):3013-21. PubMed ID: 21481400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An LC-MS/MS method for quantification of abiraterone, its active metabolites D(4)-abiraterone (D4A) and 5α-abiraterone, and their inactive glucuronide derivatives.
    Caron P; Turcotte V; Lévesque E; Guillemette C
    J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Jan; 1104():249-255. PubMed ID: 30537624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous quantification of mycophenolic acid and its glucuronide metabolites in human plasma by an UPLC-MS/MS assay.
    Zhang D; Chow DS; Renbarger JL
    Biomed Chromatogr; 2016 Oct; 30(10):1648-55. PubMed ID: 27061819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liquid Chromatography Electrospray Ionization Tandem Mass Spectrometric (LC/ESI-MS/MS) Study for the Identification and Characterization of In Vivo Metabolites of Cisplatin in Rat Kidney Cancer Tissues: Online Hydrogen/Deuterium (H/D) Exchange Study.
    Bandu R; Ahn HS; Lee JW; Kim YW; Choi SH; Kim HJ; Kim KP
    PLoS One; 2015; 10(8):e0134027. PubMed ID: 26244343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of a rapid and sensitive LC-MS/MS method for determination of exemestane and its metabolites, 17β-hydroxyexemestane and 17β-hydroxyexemestane-17-O-β-D-glucuronide: application to human pharmacokinetics study.
    Wang LZ; Goh SH; Wong AL; Thuya WL; Lau JY; Wan SC; Lee SC; Ho PC; Goh BC
    PLoS One; 2015; 10(3):e0118553. PubMed ID: 25793887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.